Pelthos Therapeutics Inc. financial data

Symbol
PTHS on NYSE
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128 % +128%
Debt-to-equity 189 %
Return On Equity -210 % -136%
Return On Assets -72.8 % +84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.06M shares -49.2%
Common Stock, Shares, Outstanding 3.09M shares -46.9%
Entity Public Float 6.8M USD
Common Stock, Value, Issued 67 USD -88.5%
Weighted Average Number of Shares Outstanding, Basic 3.06M shares +429%
Weighted Average Number of Shares Outstanding, Diluted 3.06M shares +429%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.41M USD
Revenue from Contract with Customer, Excluding Assessed Tax 294K USD
Research and Development Expense 1.14M USD -64.3%
General and Administrative Expense 4.31M USD +15.9%
Operating Income (Loss) -22.3M USD -131%
Nonoperating Income (Expense) -1.79M USD -306%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.7M USD -885%
Income Tax Expense (Benefit) -465K USD
Net Income (Loss) Attributable to Parent -23.6M USD -134%
Earnings Per Share, Basic -5 USD/shares +35.2%
Earnings Per Share, Diluted -5 USD/shares -80.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.2M USD
Inventory, Net 24.1M USD
Other Assets, Current 574K USD
Assets, Current 49.8M USD +2225%
Property, Plant and Equipment, Net 10.2M USD
Operating Lease, Right-of-Use Asset 3.35M USD
Intangible Assets, Net (Excluding Goodwill) 32.5M USD
Goodwill 30.6M USD
Assets 126M USD +5808%
Accounts Payable, Current 5.67M USD
Accrued Liabilities, Current 11.9M USD +3760%
Liabilities, Current 24.8M USD +594%
Deferred Income Tax Liabilities, Net 12.9M USD
Other Liabilities, Noncurrent 26.2M USD
Liabilities 68.2M USD +1811%
Retained Earnings (Accumulated Deficit) -43.1M USD -121%
Stockholders' Equity Attributable to Parent 58.3M USD
Liabilities and Equity 126M USD +5808%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -632K USD +68.3%
Net Cash Provided by (Used in) Financing Activities 250K USD -95.6%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.09M shares -46.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.3M USD +1036%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.3K USD
Deferred Tax Assets, Valuation Allowance 5.59M USD +54.2%
Deferred Tax Assets, Gross 5.59M USD +54.2%
Operating Lease, Liability 2.85M USD
Property, Plant and Equipment, Gross 10.6M USD
Operating Lease, Liability, Current 631K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.05M USD
Additional Paid in Capital 101M USD +460%
Operating Leases, Future Minimum Payments, Due in Two Years 665K USD
Amortization of Intangible Assets 679K USD
Operating Leases, Future Minimum Payments, Due in Three Years 685K USD
Operating Leases, Future Minimum Payments Due 164K USD
Interest Expense 1.35M USD +3351%